Eugene Somoza
Overview
Explore the profile of Eugene Somoza including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
30
Citations
704
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Szaflarski M, Cubbins L, Bauldry S, Meganathan K, Klepinger D, Somoza E
J Immigr Minor Health
. 2015 Oct;
18(4):749-763.
PMID: 26438660
Immigrants often have lower rates of depression than US-natives, but longitudinal assessments across multiple racial-ethnic groups are limited. This study examined the rates of prevalent, acquired, and persisting major depression...
2.
Greer T, Ring K, Warden D, Grannemann B, Church T, Somoza E, et al.
J Glob Drug Policy Pract
. 2014 Nov;
6(1).
PMID: 25364477
Novel approaches to the treatment of stimulant abuse and dependence are needed. Clinical data examining the use of exercise as a treatment for the abuse of nicotine, alcohol, and other...
3.
Kropp F, Lilleskov M, Richards J, Somoza E
Am Indian Alsk Native Ment Health Res
. 2014 Aug;
21(2):43-65.
PMID: 25111843
In addition to disparities in rates of substance use problems, American Indians (AIs) report multiple barriers to receiving treatment services. The present study utilized intake questionnaire data and focus groups...
4.
Walker J, Winhusen T, Storkson J, Lewis D, Pariza M, Somoza E, et al.
Hum Psychopharmacol
. 2014 Aug;
29(6):537-43.
PMID: 25087849
Background: Oxidative stress can result in damage to the brain and other organs. To protect from oxidative damage, the human body possesses molecular defense systems, based on the activity of...
5.
Kosten T, Domingo C, Shorter D, Orson F, Green C, Somoza E, et al.
Drug Alcohol Depend
. 2014 May;
140:42-7.
PMID: 24793366
Aims: We evaluated the immunogenicity, efficacy, and safety of succinylnorcocaine conjugated to cholera toxin B protein as a vaccine for cocaine dependence. Methods: This 6-site, 24 week Phase III randomized...
6.
Brigham G, Slesnick N, Winhusen T, Lewis D, Guo X, Somoza E
Drug Alcohol Depend
. 2014 Mar;
138:240-3.
PMID: 24656054
Background: Detoxification with psychosocial counseling remains a standard opioid-use disorder treatment practice but is associated with poor outcomes. This study tested the efficacy of a newly developed psychosocial intervention, Community...
7.
Winhusen T, Walker J, Brigham G, Lewis D, Somoza E, Theobald J, et al.
Am J Drug Alcohol Abuse
. 2013 Jul;
39(4):227-34.
PMID: 23808868
Background: Illicit stimulant use increases oxidative stress and oxidative stress has been found to be associated with deficits in memory, attention and problem-solving. Objective: To test a model of the...
8.
Winhusen T, Lewis D, Adinoff B, Brigham G, Kropp F, Donovan D, et al.
J Subst Abuse Treat
. 2013 Jan;
44(5):541-7.
PMID: 23305820
Greater impulsivity, assessed by the Barratt Impulsiveness Scale-11 (BIS-11) and Stroop interference scores, has been associated with treatment completion in cocaine-dependent patients. This study evaluated the relationships among impulsivity, stimulant-dependence...
9.
Winstanley E, Gay J, Roberts L, Moseley J, Hall O, Beeghly B, et al.
Public Health Nurs
. 2012 Oct;
29(6):553-62.
PMID: 23078426
Prescription drug overdose is the leading cause of injury death in Ohio, as well as in 16 other states. Responding to the prescription drug epidemic is particularly challenging given the...
10.
Kropp F, Somoza E, Lilleskov M, Moccasin M, Moore M, Lewis D, et al.
Community Ment Health J
. 2012 Jul;
49(6):714-21.
PMID: 22843125
Because few data exist on substance abuse rates in American Indian (AI) communities, the Methamphetamine and Other Drug project was developed and implemented by five nodes within the National Institute...